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Abstract
It is increasingly evident that inequalities exist for Indigenous people with cancer. Incidence for all cancers combined 
is similar to or lower than that of non-Indigenous people, but incidence of cancers with a poorer prognosis, such 
as lung cancer, is higher among Indigenous people, largely due to higher rates of smoking. Indigenous Australians 
with cancer are diagnosed with more advanced disease and are less likely to receive or complete curative treatment 
than non-Indigenous Australians. Wide disparities exist in cancer survival between Indigenous and non-Indigenous 
Australians, particularly in the first year after diagnosis. The need to improve cancer-related health services for 
Indigenous Australians is apparent, however the available evidence is currently inadequate to effectively direct efforts. 
For example, despite high cancer mortality rates, there is little information about palliative care services, their models 
of care or their uptake by Indigenous cancer patients. Through an increased understanding of how cancer affects 
Indigenous Australians and the establishment of collaborations, in particular the recently funded Centre for Research 
Excellence DISCOVER-TT, and networks such as the Clinical Oncological Society of Australia, an opportunity for 
targeted efforts in improving cancer outcomes for Indigenous Australians is tangible.  
Until recently, little information has been available about 
the impact of cancer on Aboriginal and Torres Strait 
Islander (hereafter respectfully referred to as Indigenous) 
Australians. There were few Indigenous cancer survivors 
and few Indigenous health professionals specialising in 
oncology and cancer-related fields. Cancer was not viewed 
as a high priority issue, obscured by many other health 
conditions which seemingly had a much greater impact 
on Indigenous people (relative to other Australians). Now, 
based on new higher-quality data sources, it is evident 
that there is an urgent need for our health care system 
to address the specific needs of Indigenous people and 
improve its performance across the spectrum of cancer 
control, from prevention and early diagnosis to effective 
treatment, palliation and support for cancer patients and 
their families. 
Reliable semi-national cancer incidence statistics that 
cover 84% of the Indigenous population have recently 
become available.1 The incidence rate for all cancers 
combined for Indigenous people is similar to, or slightly 
lower than, that of other Australians. However, compared 
with other Australians, Indigenous Australians have much 
lower incidence of some cancers (breast, prostate, testis, 
colorectal and brain cancer, melanoma of skin, lymphoma 
and leukaemia), but much higher incidence of others (lung 
and other smoking-related cancers, cervix, uterus and liver 
cancer), many of which are largely preventable.1 In contrast 
to incidence, cancer mortality is higher for Indigenous 
than other Australians. The death rate for all cancers 
combined and for most individual cancers is higher for 
Indigenous than other Australians; for example, although 
the incidence of breast cancer is lower for Indigenous than 
other Australian women, their mortality rate is 30% higher.2
Cancer risk factors: smoking is key
The prevalence of several cancer risk factors is different 
for Indigenous than other Australians. Some of these 
are protective against cancer, such as higher melanin 
levels in skin, earlier age at first pregnancy and longer 
periods of breastfeeding. Others increase the risk of 
cancer occurrence, such as lower participation in cancer 
screening, higher prevalence of Hepatitis B infection and 
higher prevalence of smoking. 
Smoking is the single most damaging risk factor for 
Indigenous people, for cancer and many other health 
problems. Most of the cancers that occur more commonly 
among Indigenous than other Australians are smoking-
related, including lung, oesophagus, pancreas and 
stomach.1 Indigenous smoking prevalence is more than 
double that of other Australians; 47.7% of Indigenous 
people aged 18 and over were daily smokers in the most 
recent reliable national survey.3 However, indigenous 
smoking prevalence has been falling (except among women 
living in remote areas), accompanied by reductions in the 
proportion who smoke more than 20 cigarettes per day 
and increased proportions who have successfully quit.4,5 
The Council of Australian Governments has committed 
to halving the Indigenous prevalence of daily smoking 
by 2018, with commitments of nearly $140 million over 
four years.6 This investment is being used to expand 
the Indigenous tobacco control workforce, enhance 
Quitlines, and implement the first national indigenous anti-
tobacco marketing campaign, ‘Break the Chain’. This will 
complement other mainstream Australian tobacco control 
measures.
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Cancer screening
BreastScreen Australia, the National Cervical Screening 
Program and the National Bowel Cancer Screening 
Program make up the three cancer screening programs 
in Australia. 
Despite over 15 years of national coverage, the National 
Cervical Screening Program still cannot provide comparable 
information on screening participation and outcomes for 
Indigenous women because pathology request forms and 
reports, and therefore Pap test registers, do not include 
information on indigenous status. Although some regional 
studies have consistently reported lower participation 
rates in cervical screening among Indigenous than other 
women, participation rates higher than the national 
average have been reported from the Tiwi Islands in the 
Northern Territory, indicating that high participation rates 
are in fact achievable.7 
BreastScreen Australia has recently produced 
comprehensive information about breast screen 
participation and outcomes for Indigenous women for 
the first time. Compared to other Australian women, 
Indigenous women have lower screening participation 
rates (although this difference appears to be diminishing), 
are less likely to attend post-screening assessment, and 
those diagnosed with breast cancer have larger cancers.8
Indigenous Australians are significantly less likely to accept 
an invitation to screen in the national program than non-
Indigenous Australians (17.0% c/w 38.6%). Indigenous 
people have higher faecal occult blood test positivity rates 
(8.6 c/w 7.5%) than non-Indigenous participants (although 
this is not statistically significant) and a lower proportion of 
Indigenous people correctly complete the test.9
Diagnosis and treatment
Several studies from South Australia, the Northern Territory 
and Queensland have reported that Indigenous cancer 
patients have more advanced disease when diagnosed. In 
South Australia in 1988-1994, 50% of Indigenous patients 
were diagnosed with localised disease, compared with 
60% of non-Indigenous patients (adjusted for age, sex and 
cancer site).10 In the Northern Territory in 1991-2000, 30% 
of Indigenous patients with non-Hodgkins lymphoma, 
cervical, colorectal and breast cancers had localised 
disease at diagnosis, compared to 49% of non-Indigenous 
patients (four cancers combined, adjusted for cancer site 
and age), although localised disease was more common 
for Indigenous patients diagnosed with lung cancer 
(44% c/w 31%).11 In Queensland in 1997-2006, 47% of 
Indigenous people diagnosed with cancer had localised 
disease compared to 53% of non-Indigenous people 
(matched for age, sex, place of residence, cancer site and 
year of diagnosis).12 These studies highlight the need for 
identifying and reducing the barriers to early detection of 
cancer among Indigenous people.
Studies in the Northern Territory and Queensland have 
found that Indigenous cancer patients are less likely to 
be recommended for, choose and complete curative 
treatment than non-Indigenous patients. In the Northern 
Territory in 1991-2000, Indigenous patients with non-
Hodgkins lymphoma, cervical, bowel, breast and lung 
cancers were less likely to be recommended for curative 
treatment (Indigenous 59% compared with non-Indigenous 
70%); among those offered curative treatment, Indigenous 
patients were less likely to choose it (90% c/w 96%); and 
among those who chose it, Indigenous patients were less 
likely to complete it (85% c/w 94%).13
In Queensland in 1997-2002, Indigenous patients, in 
general, were also 24% less likely than non-Indigenous 
patients to receive surgery, 20% less likely to receive 
chemotherapy and 9% less likely to receive radiotherapy.12 
Indigenous patients with head and neck cancers 
(1998-2004) were significantly less likely to receive any 
cancer treatment (75% c/w 95%),14 as were Indigenous 
women with gynaecological cancers (91% c/w 98%).15 
In contrast, Indigenous women with breast cancer 
received comparable treatment to their non-Indigenous 
counterparts (96% c/w 96%) and treatment completion 
rates were similar (p>0.05).16
Taken together, these studies indicate the importance of 
reducing barriers to Indigenous patients accessing high 
quality specialist care.
Survival
Survival rates for most cancers are lower for Indigenous 
than other cancer patients. Recently in Queensland, it was 
found that Indigenous patients had much higher mortality 
than non-Indigenous patients in the first two years after 
diagnosis (50% higher in the first year, adjusted Hazard 
Ratio, 1.50; 95% CI, 1.38–1.63), but similar mortality 
thereafter (HR 1.03; 95% CI, 0.78–1.35 in the third year 
after diagnosis).17 Indigenous patients are more likely to 
have advanced disease when diagnosed and have higher 
prevalence of chronic diseases than non-Indigenous 
patients but these factors only partly explain their lower 
survival.12,13 Other factors related to cancer treatment and 
the effect of their economic, social and environmental 
circumstances may also be involved. 
Another study in Queensland found that crude cancer 
survival was 30% worse (HR 1.30, 95%CI 1.15-1.48) 
and non-cancer deaths were over twice as common 
among Indigenous than non-Indigenous cancer patients 
(HR 2.39, 95%CI 1.57-3.63). When stage at diagnosis, 
socioeconomic status, comorbidities and treatment 
uptake were taken into account, the risk of cancer death 
became non-significant.18 These results suggest that 
treatment, comorbidities and stage at diagnosis explain 
most of the poorer cancer outcomes among Indigenous 
patients. This has critical implications for the design and 
delivery of the full spectrum of health services.
Palliative care
Cancer patients comprise a large part of palliative care 
services’ caseload. Given the high cancer mortality rates 
among Indigenous Australians, culturally appropriate 
palliative care services are warranted. However, to date 
there is little information available about services on offer, 
or their uptake by Indigenous Australians with cancer. 
More broadly, a key finding from a National Indigenous 
Palliative Care Study reported a lack of comprehensive 
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data on the rates of Indigenous access to palliative 
care.19 Recent attempts have been made to increase 
Indigenous communities’ understanding of the concept of 
palliative care through the Program of Experience in the 
Palliative Approach, a national program funded in 2003 
by the Australian Government. As a result, Indigenous 
health workers have reported being more empowered by 
knowledge, skills and confidence to provide, coordinate 
or facilitate appropriate and holistic end of life care, and 
increase communication between these workers and 
specialist palliative care services.20 A study investigating 
the referral patterns to a palliative care service in the 
Northern Territory reported Indigenous patients were 
younger (54 v 70 years), more likely to be female (52 v 
29%), living rurally (52% v 12%) and more likely to die 
at home (47% v 11%) in comparison to non-Indigenous 
Australians.21 This indicates the need for these services 
to have broadly-encompassing service plans and flexible 
delivery models.
Support services
Although prevention, screening, diagnosis and treatment 
are important determinants of health outcomes for 
Indigenous people with cancer, many do not access these 
services.22, 23 Basic infrastructure and logistical issues 
such as a lack of transport and having appropriate travel 
arrangements, and suitable accommodation for both 
the patient and their support person, may also impede 
Indigenous people’s access to cancer care and treatment 
services.24 A recent Queensland study identified that 
Indigenous adult cancer patients have substantial unmet 
supportive care needs and that they have most need 
for additional support with psychological and practical 
assistance.25 In Queensland, Indigenous cancer patients 
have indicated that they most frequently accessed 
Indigenous health workers (68.8%) for support and use 
printed cancer information (66.9%) to source information 
about their cancer rather than access Cancer Council 
Helpline (12.1%).26 
Policy, programs, service models
The gaps in diagnosis, treatment and survival indicate that 
current programs and models of service delivery do not 
fully meet the needs of Indigenous Australians with cancer. 
A recent review highlighted the inadequate participation 
in and ownership of cancer health services by Aboriginal 
people outside the realm of community-controlled health 
services, as well as a shortage of Indigenous cancer care 
workers. Both deficiencies can have a major impact on 
Indigenous people’s use of cancer services.27 The National 
Cancer Control Initiative recommended “… that the needs 
of special populations, especially Aboriginal peoples, be 
the focus of special efforts to bridge the current gaps 
in access to and utilisation of culturally sensitive cancer 
service.”28  
Some service initiatives appear to be implemented 
successfully, but formal evaluations have been rare. 
For example, telemedicine services have been used to 
overcome some of the barriers to access and utilisation of 
medical services by Indigenous cancer patients, especially 
those living in rural and remote areas. Teleoncology allows 
the patient to stay in their community for treatment and/or 
follow-up. The patient and their family, in the presence of 
a health worker, doctor or nurse, are able to link in at their 
local health centre via video conference with the specialist 
located elsewhere. This model of care has received high 
satisfaction levels when delivered to Indigenous patients 
located in remote areas of North Queensland.29 
Recent national initiatives
The first national meeting to focus on cancer as a health 
issue for Indigenous Australians was convened by Cancer 
Council Australia in Darwin in 2004, the proceedings of 
which were published in a dedicated issue of Cancer 
Forum.30, 31 From this workshop, Cancer Council Australia 
established a working party to focus on cancer control 
for Indigenous Australians. In 2010, Cancer Australia 
commissioned a report to provide direction for reducing 
the disparities Indigenous people experience across the 
cancer control continuum. This report was published 
in July 2010; Cancer Australia is still considering what 
actions to take. 
In December 2010, the Lowitja Institute hosted a national 
workshop on priorities for indigenous cancer research 
in partnership with the Queensland Institute of Medical 
Research. This workshop was widely supported by 
leading cancer experts, Indigenous survivors, Indigenous 
community representatives and advocacy groups.32  As a 
direct result of this workshop, a collaboration of Australia’s 
leading researchers working in the area of cancer in 
Indigenous Australians, together with collaborators from 
New Zealand, Canada and the United States, developed 
a proposal for a Centre for Research Excellence in 
Indigenous Cancer Control, which was funded by the 
National Health and Medical Research Council in 2012. 
This new national centre, DISCOVER-TT (Discovering 
Indigenous Strategies to improve Cancer Outcomes via 
Engagement, Research Translation and Training), was 
established in late 2012. The DISCOVER-TT research 
program will address some of the key recommendations 
of the Cancer Australia review, particularly those relating to 
pathways and outcomes of care and improving models of 
care and service delivery. An international conference on 
cancer in Indigenous peoples is planned for 2014. One of 
DISCOVER-TT’s first initiatives has been to establish the 
National Indigenous Cancer Network (NICaN), a network 
devoted to making sure that what is known about cancer 
in Indigenous Australians is available to people with cancer, 
their families, practitioners, policy makers and researchers. 
NICaN has been developed through a partnership involving 
the Menzies School of Health Research, the Australian 
Indigenous HealthInfoNet, the Lowitja Institute and Cancer 
Council Australia. For more information or to join NICaN, 
visit www.cancerinfonet.org.au.
The Clinical Oncological Society or Australia (COSA) is 
Australia’s peak national body representing multidisciplinary 
health professionals whose work encompasses cancer 
control and care. COSA members are doctors, nurses, 
scientists and allied health professionals involved in the 
clinical care of cancer patients, and therefore have the 
potential to play an important role in addressing poorer 
survival outcomes for Indigenous Australians. At COSA's 
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Annual Scientific Meeting in 2012, inequalities in cancer 
care were highlighted across a number of poster and oral 
sessions. COSA embraced this further by including in 
the program a plenary session on inequalities in cancer 
care, which included a presentation on ‘Inequality in 
cancer care for Indigenous Australians’ and a symposium 
on ‘Translating the evidence to improve cancer care for 
Indigenous people’. 
With the momentum and synergies established through 
these national partnerships, it is anticipated that inequities 
that exist for Indigenous Australians with cancer won’t be 
overlooked, and that prevention and treatment strategies 
will be enhanced, translating to improved survival and 
quality of life for Indigenous people. 
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